CHTH — CNL Healthcare Properties Income Statement
0.000.00%
FinancialsHighly SpeculativeMid CapNeutral
- $956.78m
- $1.50bn
- $322.66m
- 62
- 48
- 51
- 55
Annual income statement for CNL Healthcare Properties, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 314 | 326 | 307 | 295 | 323 |
Cost of Revenue | |||||
Gross Profit | 117 | 123 | 99.9 | 84.9 | 81.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 294 | 284 | 285 | 296 | 305 |
Operating Profit | 19.8 | 41.6 | 21.7 | -0.177 | 17.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -22.1 | 4.28 | 4.16 | -18.7 | 0.128 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.8 | 2.07 | 3.06 | -22.9 | -0.412 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -25.1 | 351 | 3.91 | -22.9 | -1.45 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.1 | 351 | 3.91 | -22.9 | -1.45 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.105 | 0.014 | 0.012 | -0.095 | -0.063 |
Dividends per Share | |||||
Special Dividends per Share |